No differences were observed between the placebo and APE groups in the CD8+ T cell/lymphocyte ratio and the CD4+/CD8+ ratio (p = 0.6546 and 0.1378, respectively). The gene discussed is CD8A; the disease is apparent mineralocorticoid excess.